Literature DB >> 21093533

Regulation and deregulation of mRNA translation during myeloid maturation.

Arati Khanna-Gupta1.   

Abstract

Gene expression in the eukaryotic cell is regulated at a number of levels, including transcription of genomic DNA into messenger RNA (mRNA), nucleocytoplasmic export of mRNA, and translation of the exported mRNA into proteins in the cytoplasm by ribosomes. The role played by epigenetics and transcription factors associated with the control of gene expression in the developing neutrophil has been well documented and appreciated over the years. A wealth of information on the role played by transcription factors in myeloid biology has contributed to our understanding of both normal and abnormal neutrophil development. However, regulation of mRNA translation in myeloid cell maturation is much less well-studied. A better understanding of the translational control of myeloid gene expression may provide important insights into both normal and abnormal myeloid maturation. This review summarizes our current understanding of the regulation of myeloid gene expression at the mRNA translational level.
Copyright © 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093533      PMCID: PMC3037031          DOI: 10.1016/j.exphem.2010.10.011

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  45 in total

Review 1.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

Review 2.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

3.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

Review 4.  Translational control of eukaryotic gene expression.

Authors:  Katrien Van Der Kelen; Rudi Beyaert; Dirk Inzé; Lieven De Veylder
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Jul-Aug       Impact factor: 8.250

Review 5.  Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.

Authors:  Sophie Park; Nicolas Chapuis; Jérôme Tamburini; Valérie Bardet; Pascale Cornillet-Lefebvre; Lise Willems; Alexa Green; Patrick Mayeux; Catherine Lacombe; Didier Bouscary
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

6.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 7.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

8.  Thrombopoietin production is inhibited by a translational mechanism.

Authors:  N Ghilardi; A Wiestner; R C Skoda
Journal:  Blood       Date:  1998-12-01       Impact factor: 22.113

9.  Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells.

Authors:  Peggy Kirstetter; Mikkel B Schuster; Oksana Bereshchenko; Susan Moore; Heidi Dvinge; Elke Kurz; Kim Theilgaard-Mönch; Robert Månsson; Thomas A Pedersen; Thomas Pabst; Evelin Schrock; Bo T Porse; Sten Eirik W Jacobsen; Paul Bertone; Daniel G Tenen; Claus Nerlov
Journal:  Cancer Cell       Date:  2008-04       Impact factor: 31.743

10.  Bcr-Abl kinase modulates the translation regulators ribosomal protein S6 and 4E-BP1 in chronic myelogenous leukemia cells via the mammalian target of rapamycin.

Authors:  Chi Ly; Adrian F Arechiga; Junia V Melo; Craig M Walsh; S Tiong Ong
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  5 in total

1.  Bone Marrow Failure Syndromes: The Ribosomopathies.

Authors:  Arati Khanna-Gupta
Journal:  J Bone Marrow Res       Date:  2013-01-10

2.  L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.

Authors:  Elspeth M Payne; Maria Virgilio; Anupama Narla; Hong Sun; Michelle Levine; Barry H Paw; Nancy Berliner; A Thomas Look; Benjamin L Ebert; Arati Khanna-Gupta
Journal:  Blood       Date:  2012-06-25       Impact factor: 22.113

3.  Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Arati Khanna-Gupta; Nirmalee Abayasekara; Michelle Levine; Hong Sun; Maria Virgilio; Navid Nia; Stephanie Halene; Paolo Sportoletti; Jee-Yeong Jeong; Pier Paolo Pandolfi; Nancy Berliner
Journal:  J Biol Chem       Date:  2012-07-31       Impact factor: 5.157

4.  An expression atlas of human primary cells: inference of gene function from coexpression networks.

Authors:  Neil A Mabbott; J Kenneth Baillie; Helen Brown; Tom C Freeman; David A Hume
Journal:  BMC Genomics       Date:  2013-09-20       Impact factor: 3.969

Review 5.  The emerging roles of ribosome biogenesis in craniofacial development.

Authors:  Adam P Ross; Konstantinos S Zarbalis
Journal:  Front Physiol       Date:  2014-02-04       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.